Home » Topics » Regulatory » Patents

Patents
RSS

New antidiabetic agents from Yamanouchi have a dual mechanism of action

Dec. 16, 1998

Antipruritic, immunosuppressive MS-444 derivatives reported by Kyowa Hakko

Dec. 15, 1998

New antitumor compounds presented by Kyorin

Dec. 15, 1998

Anticoagulant cyclic diaza compounds reported by Cor Therapeutics

Dec. 15, 1998

Another series of adenosine kinase inhibitors patented by Abbott

Dec. 11, 1998

Noninfectious HIV particles as immunogens for treating or preventing HIV infection/AIDS

Dec. 11, 1998

Adenosine absorption inhibitors from Kyowa Hakko useful as antiinflammatories, cardioprotectants

Dec. 11, 1998

Quinolinomorphinans for ischemic, hemorrhagic, traumatic or degenerative brain disorders

Dec. 11, 1998

Orally bioavailable anti-HIV peptides described in patent literature by Japan Energy

Dec. 10, 1998

Wide series of adenosine kinase inhibitors undergoing evaluation at Abbott

Dec. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...